Citadel Advisors (Ken Griffin) — NBIX Trade History
Quarter-by-quarter changes in the NEUROCRINE BIOSCIENCES INC position · CUSIP 64125C109
Currently held · 4 YearsFirst seen: 2015 Q4
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-09-02 | Reduce | 11,863 | -46,105 | -79.5% | $2.0M | — |
| 2026 Q1 | 2026-05-15 | Reduce | 57,968 | -21,743 | -27.3% | $7.6M | 0.00% |
| 2025 Q4 | 2026-02-17 | Reduce | 79,711 | -713,528 | -90.0% | $11.3M | 0.00% |
| 2025 Q3 | 2025-11-14 | Reduce | 793,239 | -1,255,836 | -61.3% | $111.4M | 0.02% |
| 2025 Q2 | 2025-08-14 | Add | 2,049,075 | 1,160,047 | +130.5% | $257.5M | 0.04% |
| 2025 Q1 | 2025-05-15 | Reduce | 889,028 | -1,649,081 | -65.0% | $98.3M | 0.02% |
| 2024 Q4 | 2025-02-14 | Add | 2,538,109 | 773,519 | +43.8% | $346.5M | 0.06% |
| 2024 Q3 | 2024-11-14 | Add | 1,764,590 | 1,023,651 | +138.2% | $203.3M | 0.04% |
| 2024 Q2 | 2024-08-14 | Reduce | 740,939 | -100,379 | -11.9% | $102.0M | 0.02% |
| 2024 Q1 | 2024-05-15 | Add | 841,318 | 729,318 | +651.2% | $116.0M | 0.02% |
| 2023 Q4 | 2024-02-14 | Reduce | 112,000 | -624,207 | -84.8% | $14.8M | 0.00% |
| 2023 Q3 | 2023-11-14 | Reduce | 736,207 | -570,066 | -43.6% | $82.8M | 0.02% |
| 2023 Q2 | 2023-08-14 | Add | 1,306,273 | 831,881 | +175.4% | $123.2M | 0.03% |
| 2023 Q1 | 2023-05-15 | Add | 474,392 | 288,824 | +155.6% | $48.0M | 0.01% |
| 2022 Q4 | 2023-02-14 | Reduce | 185,568 | -50,078 | -21.3% | $22.2M | 0.01% |
| 2022 Q3 | 2022-11-14 | New | 235,646 | 235,646 | — | $25.0M | 0.01% |
| 2022 Q2 | 2022-08-15 | Sold out | — | -93,098 | -100.0% | — | — |
| 2022 Q1 | 2022-05-16 | New | 93,098 | 93,098 | — | $8.7M | 0.00% |
| 2021 Q3 | 2022-03-11 | Sold out | — | -822,829 | -100.0% | — | — |
| 2021 Q4 | 2022-02-14 | Add | 822,829 | 154,843 | +23.2% | $70.1M | 0.01% |
| 2021 Q2 | 2021-08-16 | Reduce | 667,986 | -467,361 | -41.2% | $65.0M | 0.01% |
| 2021 Q1 | 2021-05-21 | Reduce | 1,135,347 | -12,160 | -1.1% | $110.4M | 0.03% |
| 2020 Q4 | 2021-02-16 | Add | 1,147,507 | 836,009 | +268.4% | $110.0M | 0.03% |
| 2020 Q3 | 2020-11-16 | Add | 311,498 | 167,143 | +115.8% | $30.0M | 0.01% |
| 2020 Q2 | 2020-08-14 | Reduce | 144,355 | -852,854 | -85.5% | $17.6M | 0.01% |
| 2020 Q1 | 2020-05-15 | Add | 997,209 | 573,054 | +135.1% | $86.3M | 0.04% |
| 2019 Q4 | 2020-02-14 | New | 424,155 | 424,155 | — | $45.6M | 0.02% |
| 2019 Q2 | 2020-02-14 | — | — | — | — | — | — |
| 2018 Q4 | 2019-11-14 | Sold out | — | -180,177 | -100.0% | — | — |
| 2019 Q3 | 2019-11-14 | New | 180,177 | 180,177 | — | $16.2M | 0.01% |
| 2018 Q2 | 2019-08-14 | — | — | — | — | — | — |
| 2018 Q3 | 2019-05-15 | Sold out | — | -50,790 | -100.0% | — | — |
| 2019 Q1 | 2019-05-15 | New | 50,790 | 50,790 | — | $4.5M | 0.00% |
| 2018 Q1 | 2019-02-14 | Sold out | — | -537,407 | -100.0% | — | — |
| 2017 Q4 | 2018-02-09 | Add | 537,407 | 320,800 | +148.1% | $41.7M | 0.03% |
| 2017 Q3 | 2017-11-09 | Add | 216,607 | 200,055 | +1208.6% | $13.3M | 0.01% |
| 2017 Q2 | 2017-08-11 | Reduce | 16,552 | -961,980 | -98.3% | $761.0K | 0.00% |
| 2017 Q1 | 2017-05-12 | Add | 978,532 | 717,664 | +275.1% | $42.4M | 0.04% |
| 2016 Q4 | 2017-02-10 | Reduce | 260,868 | -873,956 | -77.0% | $10.1M | 0.01% |
| 2015 Q4 | 2017-01-31 | New | 1,134,824 | 1,134,824 | — | $64.2M | 0.07% |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.